Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-04-005175
Filing Date
2004-10-14
Accepted
2004-10-14 16:37:46
Documents
8
Period of Report
2004-07-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d60906_10-k.txt 10-K 366432
2 SUBSIDIARIES OF THE REGISTRANT d60906_ex21-1.txt EX-21.1 144
3 CONSENTS OF EXPERTS AND COUNSEL d60906_ex23-1.txt EX-23.1 949
4 CONSENTS OF EXPERTS AND COUNSEL d60906_ex23-2.txt EX-23.2 1654
5 CERTIFICATIONS REQUIRED UNDER SECTION 302 d60906_ex31-1.txt EX-31.1 4015
6 CERTIFICATIONS REQUIRED UNDER SECTION 302 d60906_ex31-2.txt EX-31.2 4123
7 CERTIFICATIONS REQUIRED UNDER SECTION 906 d60906_ex32-1.txt EX-32.1 1614
8 CERTIFICATIONS REQUIRED UNDER SECTION 906 d60906_ex32-2.txt EX-32.2 1726
  Complete submission text file 0001169232-04-005175.txt   383195
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 041079216
SIC: 2836 Biological Products, (No Diagnostic Substances)